03/06/2013 - 7:31am

Acura Pharmaceuticals announced that its next-generation pseudoephedrine with abuse-deterrent technology will now be stocked by North Carolina's Kerr Drug.

03/06/2013 - 7:20am

Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors.

03/05/2013 - 2:11pm

Ranbaxy Labs will market a drug for depression under an agreement with another company, the drug maker said Tuesday.

03/05/2013 - 1:56pm

Hospira has appointed one of the founding members of its legal leadership team to corporate VP, general counsel and secretary, the company said.

03/05/2013 - 1:52pm

The Global Market Development Center on Friday announced five new member representatives to its board for a two-year term.

03/05/2013 - 1:40pm

The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.

03/05/2013 - 1:40pm

Chummies, an innovative friendship bracelet, hit the market on Tuesday. The silicone, latex-free interlocking bracelets are sold in pairs and can be pulled apart to give to various close friends, or "chums."

03/05/2013 - 1:24pm

LaRoche-Posay skin care company is challenging its fans to start something new in their life and to be confident in their clear skin with the new Clear Commitments contest, a movement created to inspire people to make "clear" and simple commitments for themselves on a new challenge they want to accomplish this year.

03/05/2013 - 11:56am

Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.